[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-359706-105":59,"doc-detail-359706-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","self-efficacy-in-the-managing-late-sequelae-in-long-term-breast-cancer-survivors-in-spain","Self-efficacy in the managing late sequelae in long-term breast cancer survivors in Spain","","Self-efficacy in managing late and long-term effects was assessed among breast cancer survivors living at least five years after diagnosis. A cross-sectional study recruited 188 women through intentional sampling, using social media and multiple media channels plus patient associations. Self-efficacy was measured with the SEMCD-S scale, and analyses used descriptive statistics, bivariate tests, and multiple regression. Participants averaged 57.5 years of age and 10.2 years survival; SEMCD-S averaged 6.4 (0–10). Tobacco consumption and comorbidities showed significant associations, while comorbidity was the only significant negative predictor in regression, accounting for 2.53% variance.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/self-efficacy-in-the-managing-late-sequelae-in-long-term-breast-cancer-survivors-in-spain/359706/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/self-efficacy-in-the-managing-late-sequelae-in-long-term-breast-cancer-survivors-in-spain/359706.png","ImageObject",300,407,{"name":92,"@type":93},"Riley West","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What did the study evaluate in long-term breast cancer survivors in Spain?","Question",{"text":112,"@type":113},"It evaluated self-efficacy for managing late sequelae among survivors who had lived beyond five years after diagnosis, along with sociodemographic, clinical, and lifestyle factors.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was self-efficacy measured and what statistical methods were used?",{"text":117,"@type":113},"Self-efficacy was measured using the self-efficacy for managing chronic disease scale (SEMCD-S). The study used descriptive statistics, bivariate tests, and multiple regression to identify predictors.",{"name":119,"@type":110,"acceptedAnswer":120},"What factors were associated with self-efficacy in the study?",{"text":121,"@type":113},"Self-efficacy was significantly associated with tobacco consumption and the presence of comorbidities. In the regression model, only comorbidity remained a significant negative predictor.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},359706,1790194815,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145},1099523885074,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nSelf-efficacy in the managing late sequelae in long-term breast cancer survivors in Spain  \nNelia Soto-Ruiz1,2, Paula Escalada-Hernández1,2􀀍,  \nGustavo Adolfo Pimentel-Parra1,2, Ana Carolina Andrade Biaggi Leite1,2  \n,  \nArantxa Bujanda-Sainz De Murieta1,2 & Cristina García-Vivar1,2  \nThis study assessed self-efficacy in managing long-term effects among breast cancer survivors living beyond five years post-diagnosis, as well as associated sociodemographic, clinical, and lifestyle factors. A cross-sectional design was conducted with 188 women recruited through intentional sampling. Recruitment was carried out through dissemination on social media, print and digital media, radio and television, as well as collaboration with regional patient associations. Sociodemographic, clinical, and lifestyle data were collected, and self-efficacy was measured using the self-efficacy for managing chronic disease scale (SEMCD-S). Analyses included descriptive statistics, bivariate tests, and multiple regression to identify predictors of self-efficacy. Participants had a mean age of 57.5 years and an average survival time of 10.2 years. The mean SEMCD-S score was 6.4 (range 0–10), indicating a moderate level of self-efficacy. Significant associations were found between self-efficacy and tobacco consumption (p \u003C 0.05), as well as with the presence of comorbidities (p = 0.013) . In the regression model, only comorbidity remained a significant negative predictor, accounting for 2.53% of the variance. In summary, long-term breast cancer survivors reported moderate self-efficacy in managing chronic disease effects. Comorbidities emerged as a key factor negatively influencing self-efficacy. These findings suggest the need for targeted interventions to enhance self-efficacy and improve quality of life in this growing survivor population.  \nKeywords Breast cancer survivors, Cross-sectional studies, Health behaviour, Lifestyle, Long-term effects, quality of life, Self-efficacy, Sociodemographic factors  \nBreast cancer (BC) is the most prevalent form of cancer among women worldwide; a total of 2.3 million diagnoses of BC were estimated in 2022, accounting for 11.6% of all cancer diagnoses1. Despite this prevalence, because of early detection programmes and advances in treatments, an increasing number of women are able to overcome the disease and thus become long-term breast cancer survivors (LT-BCSs), a term that refers to individuals who have survived five years or more following their initial diagnosis2. In fact, BC is characterized by the highest survival rate among cancers, and its survivors represent the largest group of cancer survivor3; namely, the population of breast cancer survivors (BCSs) includes more than 8.2 million individuals1.  \nHowever, in many cases, breast cancer survival is accompanied by late and long-term sequelae that can significantly impact survivors’ quality of life4–6. BCSs experience physical problems such as fatigue, pain and lymphedema and psychological effects such as depression and anxiety7–11. Some of these symptoms may improve over time, although certain late effects persist12–14. Accordingly, many BCSs may not live the rest oftheir lives in the same way as do other women of their own age who have not experienced cancer15.  \nIn this context, self-efficacy has been identified as a key concept with respect to the adaptation of LT-BCSs. It represents a crucial influence on the ability of people with cancer to manage their symptoms both during and after treatment16. The concept of self-efficacy, which was developed by Bandura (1977), refers to an individual’s belief in their ability to perform the behaviours necessary to achieve specific performance goals. That is, this term refers to the individual’s perceived ability to engage in a specific behaviour. Self-efficacy has been identified as a fundamental component of self-care because people tend","cbCaiq06Y12oYKyi","https://ap.wps.com/l/cbCaiq06Y12oYKyi","pdf",1527571,11,"English","# Background\n# Self-efficacy concept and relevance\n# Study design and participants\n# Measures and analysis\n# Results and implications","[{\"question\":\"What did the study evaluate in long-term breast cancer survivors in Spain?\",\"answer\":\"It evaluated self-efficacy for managing late sequelae among survivors who had lived beyond five years after diagnosis, along with sociodemographic, clinical, and lifestyle factors.\"},{\"question\":\"How was self-efficacy measured and what statistical methods were used?\",\"answer\":\"Self-efficacy was measured using the self-efficacy for managing chronic disease scale (SEMCD-S). The study used descriptive statistics, bivariate tests, and multiple regression to identify predictors.\"},{\"question\":\"What factors were associated with self-efficacy in the study?\",\"answer\":\"Self-efficacy was significantly associated with tobacco consumption and the presence of comorbidities. In the regression model, only comorbidity remained a significant negative predictor.\"}]","Self-efficacy in the managing late sequelae in long-term breast cancer survivors in Spain | PDF",1790137593,28]